Holen Sie sich die Stockscreener-App
0.76
20.85%
0.1311
Handel nachbörslich:
.76
Schlusskurs vom Vortag:
$0.6289
Offen:
$0.6408
24-Stunden-Volumen:
287.52K
Relative Volume:
1.05
Marktkapitalisierung:
$12.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.56M
KGV:
-0.386
EPS:
-1.9688
Netto-Cashflow:
$-21.21M
1W Leistung:
+23.10%
1M Leistung:
+30.03%
6M Leistung:
-81.46%
1J Leistung:
-57.78%
1-Tages-Spanne:
$0.6388
$0.7899
1-Wochen-Bereich:
$0.6069
$0.7899
52-Wochen-Spanne:
$0.4606
$7.20
Calcimedica Inc Stock (CALC) Company Profile
Firmenname
Calcimedica Inc
Sektor
Branche
Telefon
858-952-5500
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
0.76 | 9.94M | 0 | -29.56M | -21.21M | -1.9688 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
Number of shareholders of CalciMedica, Inc. – NASDAQ:CALC - TradingView
CALC Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Clinical-Stage InvestmentsTrading Community - Newser
CalciMedica (CALC) Rises +4.47%: Technicals vs Fundamentals — Which Wins? 2026-05-21Trading Community - Newser
CalciMedica (CALC) reporting person holds 0 shares after amendment - Stock Titan
CalciMedica, Inc. (CALC) Fundamental Analysis - Meyka
Analysts Are Bullish on These Healthcare Stocks: Meiragtx Holdings (MGTX), CalciMedica (CALC) - The Globe and Mail
CalciMedica (CALC) Q4 2025 Disappoints — EPS $-0.73 Below $-0.42 ViewsInvestment Community - Newser
Analysts Have Conflicting Sentiments on These Healthcare Companies: West Pharmaceutical Services (WST), CalciMedica (CALC) and Tyra Bioscience (TYRA) - The Globe and Mail
[10-Q] CalciMedica, Inc. Quarterly Earnings Report - Stock Titan
CalciMedica Releases Q1 2026 Financial Results - AlphaStreet
CalciMedica Reports Q1 2026 Financial Results, Advances Auxora and CM5480 Clinical Programs - Minichart
TradingKey - TradingKey
CalciMedica posts Q1 profit on higher other income, lower expenses - TradingView
CalciMedica (NASDAQ: CALC) swings to Q1 profit as expenses decline - Stock Titan
Press Release: CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates - Moomoo
[SCHEDULE 13G/A] CalciMedica, Inc. Amended Passive Investment Disclosure - Stock Titan
CalciMedica Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
CalciMedica (CALC) details 2025 executive pay, ownership and $20.4M raise - Stock Titan
CALC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is CalciMedica (CALC) stock a long-term winner | Q4 2025: Earnings UnderperformMarket Expert Watchlist - Newser
CalciMedica (CALC) Stock: Sentiment Analysis | Q4 2025: Below ExpectationsSector Outperform - Xã Châu Thành
CALC Options Chain — NASDAQ:CALC - TradingView
MACD Signal: Does CalciMedica Inc outperform in volatile marketsMarket Sentiment Report & AI Enhanced Trading Alerts - baoquankhu1.vn
Profit Review: Does CalciMedica Inc have consistent dividend growth2026 Growth vs Value & Accurate Technical Buy Alerts - baoquankhu1.vn
EPS Watch: Is CalciMedica Inc attractive for institutional investorsPortfolio Gains Summary & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Jobs Data: Is CalciMedica Inc exposed to currency risks2026 PostEarnings & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
CalciMedica (NASDAQ: CALC) grants CSO 65,124 options at $0.585 - Stock Titan
CalciMedica (CALC) CFO receives 67,728 stock options at $0.585 strike price - Stock Titan
CalciMedica (CALC) grants 65,124 stock options to President and COO - Stock Titan
Earnings Risk: Does CalciMedica Inc meet Warren Buffetts criteriaMarket Growth Review & Fast Momentum Entry Tips - baoquankhu1.vn
CALC PE Ratio & Valuation, Is CALC Overvalued - Intellectia AI
CALC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CalciMedica (CALC) price target decreased by 24.39% to 10.54 - MSN
If You Invested $1,000 in CALCIMEDICA INC (CALC) - Stock Titan
Revenue Check: Does CalciMedica Inc meet Warren Buffetts criteria2026 Drop Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Big Picture: Does CalciMedica Inc meet Warren Buffetts criteriaShare Buyback & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
CalciMedica receives Nasdaq delisting notices for market value and bid price - Investing.com Australia
CalciMedica Receives Nasdaq Deficiency Notices on Listing Standards - TipRanks
CalciMedica Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
CalciMedica (NASDAQ: CALC) faces Nasdaq market value and $1 bid price breaches - Stock Titan
Analysis Recap: Can CalciMedica Inc outperform in the next rally2026 News Drivers & Fast Entry High Yield Stock Tips - baoquankhu1.vn
US Market Recap: Is CalciMedica Inc stock a smart retirement pick2026 Price Momentum & Daily Price Action Insights - baoquankhu1.vn
Latest CALC NewsCalciMedica Reports Second Quarter 2023 Fin... - Stock Titan
[EFFECT] CalciMedica, Inc. SEC Filing - Stock Titan
Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), CalciMedica (CALC) - The Globe and Mail
Oppenheimer Cuts CalciMedica (NASDAQ:CALC) Price Target to $10.00 - Defense World
Aug Highlights: Can CalciMedica Inc outperform in the next rally2025 Top Gainers & Consistent Profit Trading Strategies - baoquankhu1.vn
Performance Recap: Should I set a stop loss on CalciMedica Inc2025 Momentum Check & Safe Entry Point Identification - baoquankhu1.vn
CalciMedica, Inc. Common Stock share price - livemint.com
CalciMedica (CALC) Receives Updated Analyst Rating from Oppenhei - GuruFocus
Oppenheimer Adjusts CalciMedica Price Target to $10 From $20, Maintains Outperform Rating - marketscreener.com
Finanzdaten der Calcimedica Inc-Aktie (CALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):